1. World Health Organization Regional Office for Africa. Outbreaks and Emergencies Bulletin. Cité du Djoué, Brazzaville, Republic of the Congo: World Health Organization Regional Office for Africa; 2024. https://www.afro.who.int/health-topics/disease-outbreaks/outbreaks-and-other-emergencies-updates?page=0
2. World Health Organization. Ebola virus disease vaccines. Geneva, Switzerland: World Health Organization; 2023. https://www.who.int/news-room/questions-and-answers/item/ebola-vaccines
3. Merck. U.S. FDA approves Merck’s ERVEBO (Ebola Zaire Vaccine, Live) for use in children 12 months of age and older. [Press release]. Rahway, NJ: Merck; 2023. https://www.merck.com/news/u-s-fda-approves-mercks-ervebo-ebola-zaire-vaccine-live-for-use-in-children-12-months-of-age-and-older/
4. World Health Organization. Meeting of the Strategic Advisory Group of Experts on Immunization, 22–24 March 2021: conclusions and recommendations. Geneva, Switzerland: World Health Organization; 2021. https://www.who.int/publications/i/item/meeting-of-the-strategic-advisory-group-of-experts-on-immunization-22-24-march-2021-conclusions-and-recommendations
5. Case fatality risk among individuals vaccinated with rVSVΔG-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo;Coulborn;Lancet Infect Dis,2024